CuraSen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing drug candidates with broad applicability in ...
The peptide known as Fragment 176-191 (also sometimes linked with AOD-9604 in its analog forms) is a truncated portion of ...
Background Since the 1960s, beta blockers have been used to treat hypertrophic obstructive cardiomyopathy (HOCM), a genetic ...
A macromolecular JAK inhibitor shows anti-inflammatory activities similar to or better than existing drugs in inflammatory cells and mouse models of acute injury and endotoxaemia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback